Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-3 of 3 for your search:
Cancer Type/Condition:
Lung cancer, non-small cell
Stage/Subtype:
occult non-small cell lung cancer
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Her2 and TGFBeta in Treatment of Her2 Positive Lung Malignancy
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
24486 HERCREEM
, NCT00889954
2.
Erlotinib Hydrochloride in Treating Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Precancerous Lesions of the Lung
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
40 to 79
Sponsor:
NCI
Protocol IDs:
NU-NWU08-11-01
, NWU08-11-01, NCI-08-11-01, RPCI-I-121507, NCT01013831
3.
Photodynamic Therapy (PDT) in Lung Cancer
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
50 to 75
Sponsor:
Other
Protocol IDs:
281-92
, PulmMed 649, NCT00984243
Select All on Page
Help with Results
